IPSEN, OOO
- Country
- 🇷🇺Russia
- Ownership
- -
- Established
- 1929-01-01
- Employees
- 5.7K
- Market Cap
- $9.8B
- Website
- https://www.ipsen.com/
Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines.
- Conditions
- Interventions
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 56
- Registration Number
- NCT04736745
- Locations
- 🇩🇪
Clinical Research Centre (CRS), Berlin, Germany
An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.
- Conditions
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 411
- Registration Number
- NCT04665323
- Locations
- 🇺🇸
Ipsen Central Contact, Cambridge, Massachusetts, United States
Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.
- Conditions
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 451
- Registration Number
- NCT04649632
- Locations
- 🇳🇱
Ipsen Facility, Hoofddorp, Netherlands
United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting
- Conditions
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 80
- Registration Number
- NCT04649580
- Locations
- 🇬🇧
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
🇬🇧Cardiff and Vale University LHB, Cardiff, United Kingdom
🇬🇧Royal Free London NHS Foundation Trust, London, United Kingdom
Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 1540
- Registration Number
- NCT04637204
- Locations
- 🇬🇧
Ipsen Facility, Slough, United Kingdom
Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.
- Conditions
- Interventions
- First Posted Date
- 2020-11-17
- Last Posted Date
- 2022-08-24
- Lead Sponsor
- Ipsen
- Registration Number
- NCT04632199
- Locations
- 🇫🇷
Centre Léon Bérard, Léon, France
🇧🇪UZ Leuven, Leuven, Belgium
🇫🇷CHU de Nantes - Hôpital Hôtel Dieu, Nantes, France
Study on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France.
- Conditions
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- Ipsen
- Registration Number
- NCT04609800
A Study to Review Treatment Outcomes From Treatment With Dysport® Injections in Adults for Upper and/or Lower Limb Focal Spasticity
- Conditions
- First Posted Date
- 2020-10-27
- Last Posted Date
- 2021-06-21
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 123
- Registration Number
- NCT04604379
- Locations
- 🇬🇧
York Hospital, York, United Kingdom
🇬🇧Kings College Hospital, London, United Kingdom
🇬🇧Colman Hospital, Norwich, United Kingdom
Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.
- Conditions
- First Posted Date
- 2020-10-20
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 817
- Registration Number
- NCT04593420
- Locations
- 🇫🇷
Ipsen Central Contact, Paris, France
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
- Conditions
- Interventions
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 161
- Registration Number
- NCT04526665
- Locations
- 🇺🇸
Keck Medical Center of USC, Los Angeles, California, United States
🇺🇸Henry Ford Health System, Novi, Michigan, United States
🇿🇦Tiervlei Trial Centre, Cape Town, Western Cape, South Africa